Related Experiment Video
Updated: Oct 5, 2025

14:14
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.0K
Dual Pallidal and Thalamic Deep Brain Stimulation for Complex Ipsilateral Dystonia
Kyung Won Chang1, Myung Ji Kim2, So Hee Park1
1Brain Research Institute, Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Medical Journal
|January 27, 2022
Summary
Dual deep brain stimulation (DBS) targeting the globus pallidus (GPi) and ventralis oralis (Vo) shows significant improvement in dystonia symptoms. This multi-target DBS approach may offer superior outcomes compared to single-target stimulation for dystonia.
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- Globus pallidus pars interna (GPi) is a recognized target for deep brain stimulation (DBS) in dystonia.
- Targeting the ventralis oralis (Vo) complex has shown promise for dystonic tremor and focal dystonia.
- Multi-target DBS may offer advantages over single-target DBS for dystonia.
Purpose of the Study:
- To evaluate the clinical outcomes of unilateral DBS targeting both the GPi and Vo in patients with medically refractory upper extremity dystonia.
- To compare the efficacy of dual-target DBS with single-target DBS.
Main Methods:
- Five patients with focal or segmental upper extremity dystonia underwent unilateral DBS.
- Two DBS electrodes were implanted targeting the ipsilateral GPi and Vo.
- Clinical outcomes were assessed using the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and Disability Rating Scale.
Main Results:
- BFMDRS scores showed sustained improvement, decreasing by up to 64% at 12 months.
- Disability Rating Scale scores improved by up to 60% at 12 months.
- Stimulating both GPi and Vo targets at 1 month post-surgery yielded better clinical scores than single-target stimulation.
Conclusions:
- Unilateral dual electrode DBS targeting both the thalamus (Vo) and globus pallidus (GPi) appears effective for dystonia.
- This dual-target approach may be as effective or superior to single-target DBS for dystonia.
- Favorable clinical outcomes were observed despite a small patient cohort.

